Reply to B. P. L. Wijnhoven et al and F. Nuytens et al

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Pages (from-to)	92-93
Number of pages	2
Journal	Journal of clinical oncology
Volume	39
Issue number	1
DOIs	https://doi.org/10.1200/JCO.20.02354
Publication status	Published - 1 Jan 2021

Access to Document

@article{e6a6fecc138a498fac04b2d686ddaecc,

title = "Reply to B. P. L. Wijnhoven et al and F. Nuytens et al",

author = "Markar, {Sheraz R.} and {van Berge Henegouwen}, {Mark I.}",

year = "2021",

month = jan,

day = "1",

doi = "https://doi.org/10.1200/JCO.20.02354",

language = "English",

volume = "39",

pages = "92--93",

journal = "Journal of clinical oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "1",

}

TY - JOUR

T1 - Reply to B. P. L. Wijnhoven et al and F. Nuytens et al

AU - Markar, Sheraz R.

AU - van Berge Henegouwen, Mark I.

PY - 2021/1/1

Y1 - 2021/1/1

UR - http://www.scopus.com/inward/record.url?scp=85098332513&partnerID=8YFLogxK

U2 - https://doi.org/10.1200/JCO.20.02354

DO - https://doi.org/10.1200/JCO.20.02354

M3 - Comment/Letter to the editor

C2 - 32946350

SN - 0732-183X

VL - 39

SP - 92

EP - 93

JO - Journal of clinical oncology

JF - Journal of clinical oncology

IS - 1

ER -